Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Ionizable lipid nanoparticles are the best for delivering gene-editing therapies.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Restoring NAD⁺ may help with aging and chronic diseases, but more research is needed.

Insulin resistance linked to obesity may increase COVID-19 severity.

Adam10 enzyme is crucial for healthy skin and proper Notch signaling.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Better nutrition may reduce fecal incontinence in stroke patients by lowering inflammation and improving antioxidant levels.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Vitamin D might help treat alopecia areata.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Special cells can help regrow hair in alopecia areata.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Thymoma with alopecia areata may be linked to abnormal immune cells.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.